Taurine: The appeal of a safe amino acid for skeletal muscle disorders

Journal of Translational Medicine

Volumn 13, Issue 1, 2015, Pages

  De Luca, Annamaria ^a   Pierno, Sabata ^a   Camerino, Diana Conte ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Development and aging; Disuse muscle atrophy; Inherited muscle disorders; Skeletal muscle performance; Taurine skeletal muscle

Indexed keywords

CHLORIDE CHANNEL; SODIUM CHANNEL NAV1.4; TAURINE; AMINO ACID; ION CHANNEL;

CELL FUNCTION; CLINICAL TRIAL (TOPIC); DISUSE INDUCED MUSCLE ATROPHY; DUCHENNE MUSCULAR DYSTROPHY; HUMAN; MALNUTRITION; MEMBRANE DEPOLARIZATION; MUSCLE ATROPHY; MUSCLE CONTRACTION; MUSCLE FUNCTION; MUSCULOSKELETAL DISEASE; MYOTONIA; NONHUMAN; PATHOPHYSIOLOGY; PERIODIC PARALYSIS; REPERFUSION INJURY; REVIEW; SARCOLEMMA; SENESCENCE; SKELETAL MUSCLE; ANIMAL; DRUG EFFECTS; EXCITATION CONTRACTION COUPLING; METABOLISM; MUSCULAR DISEASES; PATHOLOGY;

AMINO ACIDS; ANIMALS; EXCITATION CONTRACTION COUPLING; HUMANS; ION CHANNELS; MUSCLE, SKELETAL; MUSCULAR DISEASES; TAURINE;

EID: 84937890216     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/s12967-015-0610-1     Document Type: Review

References (154)

1. Huxtable RJ (1992) Physiological actions of taurine. Physiol Rev 72:101-163
2. Barle H, Ahlman B, Nyberg B, Andersson K, Essén P, Wernerman J (1996) The concentrations of free amino acids in human liver tissue obtained during laparoscopic surgery. Clin Physiol 16:217-227
3. Huxtable RJ (2000) Expanding the circle 1975-1999: sulfur biochemistry and insights on the biological functions of taurine. Adv Exp Med Biol 483:1-25
4. Schaffer SW, Jong CJ, Ramila KC, Azuma J (2010) Physiological roles of taurine in heart and muscle. J Biomed Sci 17:S2
5. Faggiano A, Melis D, Alfieri R, De Martino M, Filippella M, Milone F et al (2005) Sulfur amino acids in Cushing's disease: insight in homocysteine and taurine levels in patients with active and cured disease. J Clin Endocrinol Metab 90:6616-6622
6. Warskulat U, Flögel U, Jacoby C, Hartwig HG, Thewissen M, Merx MW et al (2004) Taurine transporter knockout depletes muscle taurine levels and results in severe skeletal muscle impairment but leaves cardiac function uncompromised. FASEB J 18:577-579
7. Stipanuk MH (2004) Role of the liver in regulation of body cysteine and taurine levels: a brief review. Neurochem Res 29:105-110
8. Lambert IH, Kristensen DM, Holm JB, Mortensen OH (2015) Physiological role of taurine-from organism to organelle. Acta Physiol (Oxf). 213:191-212
9. Wu JY, Tang XW, Tsai WH (1992) Taurine receptor: kinetic analysis and pharmacological studies. Adv Exp Med Biol 315:263-268
10. Frosini M, Sesti C, Dragoni S, Valoti M, Palmi M, Dixon HB et al (2003) Interactions of taurine and structurally related analogues with the GABAergic system and taurine binding sites of rabbit brain. Br J Pharmacol 139:1163-1171
11. Jia F, Yue M, Chandra D, Keramidas A, Goldstein PA, Homanics GE et al (2008) Taurine is a potent activator of extrasynaptic GABA(A) receptors in the thalamus. J Neurosci 28:106-115
12. Wu JY, Prentice H (2010) Role of taurine in the central nervous system. J Biomed Sci 17:S1
13. Huxtable R, Bressler R (1973) Effect of taurine on a muscle intracellular membrane. Biochim Biophys Acta 323:573-583
14. Warskulat U, Heller-Stilb B, Oermann E, Zilles K, Haas H, Lang F et al (2007) Phenotype of the taurine transporter knockout mouse. Methods Enzymol 428:439-458
15. Ito T, Kimura Y, Uozumi Y, Takai M, Muraoka S, Matsuda T et al (2008) Taurine depletion caused by knocking out the taurine transporter gene leads to cardiomyopathy with cardiac atrophy. J Mol Cell Cardiol 44:927-937
16. Ito T, Oishi S, Takai M, Kimura Y, Uozumi Y, Fujio Y et al (2010) Cardiac and skeletal muscle abnormality in taurine transporter-knockout mice. J Biomed Sci 17:S20
17. Lötsch J, Hummel T, Warskulat U, Coste O, Häussinger D, Geisslinger G et al (2014) Congenital taurine deficiency in mice is associated with reduced sensitivity to nociceptive chemical stimulation. Neuroscience 259:63-70
18. Schaffer SW, Shimada K, Jong CJ, Ito T, Azuma J, Takahashi K (2014) Effect of taurine and potential interactions with caffeine on cardiovascular function. Amino Acids 6:1147-1157
19. Shao A, Hathcock JN (2008) Risk assessment for the amino acids taurine, l-glutamine and l-arginine. Regul Toxicol Pharmacol 50:376-399
20. Seifert SM, Schaechter JL, Hershorin ER, Lipshultz SE (2011) Health effects of energy drinks on children, adolescents, and young adults. Pediatrics 127:511-528
21. Wolk BJ, Ganetsky M, Babu KM (2012) Toxicity of energy drinks. Curr Opin Pediatr 24:243-251
22. Gunja N, Brown JA (2012) Energy drinks: health risks and toxicity. Med J Aust 196:46-49
23. Taranukhin AG, Saransaari P, Oja SS (2013) Lethality of taurine and alcohol coadministration in mice. Adv Exp Med Biol 776:29-38
24. El Idrissi A, Messing J, Scalia J, Trenkner E (2003) Prevention of epileptic seizures by taurine. Adv Exp Med Biol 526:515-525
25. Adrian RH, Bryant SH (1974) On the repetitive discharge in myotonic muscle fibres. J Physiol 240:505-515
26. Conte Camerino D, Tricarico D, Desaphy JF (2007) Ion channel pharmacology. Neurotherapeutics 4:184-198
27. Jentsch TJ (2008) CLC chloride channels and transporters: from genes to protein structure, pathology and physiology. Crit Rev Biochem Mol Biol 43:3-36
28. Conte Camerino D, Franconi F, Mambrini M, Bennardini F, Failli P, Bryant SH et al (1987) The action of taurine on chloride conductance and excitability characteristics of rat striated muscle fibers. Pharmacol Res Commun 19:685-701
29. Conte Camerino D, Franconi F, Mambrini M, Mitolo-Chieppa D, Bennardini F, Failli P et al (1987) Effect of taurine on chloride conductance and excitability of rat skeletal muscle fibers. Adv Exp Med Biol 217:207-216
30. Conte Camerino D, De Luca A, Mambrini M, Ferrannini E, Franconi F, Giotti A et al (1989) The effects of taurine on pharmacologically induced myotonia. Muscle Nerve 12:898-904
31. Pierno S, Tricarico D, De Luca A, Campagna F, Carotti A, Casini G et al (1994) Effects of taurine analogues on chloride channel conductance of rat skeletal muscle fibers: a structure-activity relationship investigation. Naunyn Schmiedebergs Arch Pharmacol 349:416-421
32. Pusch M, Accardi A, Liantonio A, Ferrera L, De Luca A, Camerino DC et al (2001) Mechanism of block of single protopores of the Torpedo chloride channel ClC-0 by 2-(p-chlorophenoxy)butyric acid (CPB). J Gen Physiol 118:45-62
33. Liantonio A, Accardi A, Carbonara G, Fracchiolla G, Loiodice F, Tortorella P et al (2002) Molecular requisites for drug binding to muscle CLC-1 and renal CLC-K channel revealed by the use of phenoxy-alkyl derivatives of 2-(p-chlorophenoxy)propionic acid. Mol Pharmacol 62:265-271
34. Conte Camerino D, Tricarico D, Pierno S, Desaphy JF, Liantonio A, Pusch M et al (2004) Taurine and skeletal muscle disorders. Neurochem Res 29:135-142
35. Durelli L, Mutani R, Fassio F, Satta A, Bartoli E (1982) Taurine and hyperexcitable human muscle: effects of taurine on potassium-induced hyperexcitability of dystrophic myotonic and normal muscles. Ann Neurol 11:258-265
36. Durelli L, Mutani R, Fassio F (1983) The treatment of myotonia: evaluation of chronic oral taurine therapy. Neurology. 33:599-603
37. Trip J, Drost G, van Engelen BG, Faber CG (2006) Drug treatment for myotonia. Cochrane Database Syst Rev (1):CD004762
38. Mankodi A, Takahashi MP, Jiang H, Beck CL, Bowers WJ, Moxley RT et al (2002) Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol Cell 10:35-44
39. Lueck JD, Lungu C, Mankodi A, Osborne RJ, Welle SL, Dirksen RT et al (2007) Chloride channelopathy in myotonic dystrophy resulting from loss of posttranscriptional regulation for CLCN1. Am J Physiol Cell Physiol 292:C1291-C1297
40. Conte Camerino D, Desaphy JF, Tricarico D, Pierno S, Liantonio A (2008) Therapeutic approaches to ion channel diseases. Adv Genet 64:81-145
41. De Luca A, Pierno S, Tricarico D, Desaphy JF, Liantonio A, Barbieri M et al (2000) Taurine and skeletal muscle ion channels. Adv Exp Med Biol 483:45-56
42. Schanne OF, Dumaine R (1992) Interaction of taurine with the fast Na-current in isolated rabbit myocytes. J Pharmacol Exp Ther 263:1233-1240
43. Satoh H (1998) Inhibition of the fast Na+ current by taurine in guinea pig ventricula myocytes. Gen Pharmacol 31:155-157
44. De Luca A, Natuzzi F, Desaphy JF, Loni G, Lentini G, Franchini C et al (2000) Molecular determinants of mexiletine structure for potent and use-dependent block of skeletal muscle sodium channels. Mol Pharmacol 57:268-277
45. De Luca A, Talon S, De Bellis M, Desaphy JF, Lentini G, Corbo F et al (2003) Optimal requirements for high affinity and use-dependent block of skeletal muscle sodium channel by N-benzyl analogs of tocainide-like compounds. Mol Pharmacol 64:932-945
46. De Luca A, Pierno S, Liantonio A, Desaphy JF, Natuzzi F, Didonna MP et al (2004) New potent mexiletine and tocainide analogues evaluated in vivo and in vitro as antimyotonic agents on the myotonic ADR mouse. Neuromuscul Disord 14:405-416
47. De Luca A, De Bellis M, Corbo F, Franchini C, Muraglia M, Catalano A et al (2012) Searching for novel anti-myotonic agents: pharmacophore requirement for use-dependent block of skeletal muscle sodium channels by N-benzylated cyclic derivatives of tocainide. Neuromuscul Disord 22:56-65
48. De Luca A, Pierno S, Conte Camerino D (1996) Effect of taurine depletion on excitation-contraction coupling and Cl− conductance of rat skeletal muscle. Eur J Pharmacol 296:215-222
49. Pierno S, De Luca A, Huxtable RJ, Conte Camerino D (1994) Dual effects of taurine on membrane ionic conductances of rat skeletal muscle fibers. Adv Exp Med Biol 359:217-224
50. Hamilton EJ, Berg HM, Easton CJ, Bakker AJ (2006) The effect of taurine depletion on the contractile properties and fatigue in fast-twitch skeletal muscle of the mouse. Amino Acids 31:273-278
51. Ito T, Yoshikawa N, Schaffer SW, Azuma J (2014) Tissue taurine depletion alters metabolic response to exercise and reduces running capacity in mice. J Amino Acids. 2014:964680
52. Bakker AJ, Berg HM (2002) Effect of taurine on sarcoplasmic reticulum function and force in skinned fast-twitch skeletal muscle fibres of the rat. J Physiol 538:185-194
53. Dutka TL, Lamboley CR, Murphy RM, Lamb GD (2014) Acute effects of taurine on sarcoplasmic reticulum Ca2+ accumulation and contractility in human type I and type II skeletal muscle fibers. J Appl Physiol (1985) 117:797-805
54. Goodman CA, Horvath D, Stathis C, Mori T, Croft K, Murphy RM et al (2009) Taurine supplementation increases skeletal muscle force production and protects muscle function during and after high-frequency in vitro stimulation. J Appl Physiol 107:144-154
55. Silva LA, Silveira PC, Ronsani MM, Souza PS, Scheffer D, Vieira LC et al (2011) Taurine supplementation decreases oxidative stress in skeletal muscle after eccentric exercise. Cell Biochem Funct 29:43-49
56. Sugiura H, Okita S, Kato T, Naka T, Kawanishi S, Ohnishi S et al (2013) Protection by taurine against INOS-dependent DNA damage in heavily exercised skeletal muscle by inhibition of the NF-κB signaling pathway. Adv Exp Med Biol 775:237-246
57. Tallis J, Higgins MF, Cox VM, Duncan MJ, James RS (2014) Does a physiological concentration of taurine increase acute muscle power output, time to fatigue, and recovery in isolated mouse soleus (slow) muscle with or without the presence of caffeine? Can J Physiol Pharmacol 92:42-49
58. Cozzoli A, Rolland JF, Caporosso RF, Sblendorio VT, Longo V, Simonetti S et al (2011) Evaluation of potential synergistic action of a combined treatment with alpha-methyl-prednisolone and taurine on the mdx mouse model of Duchenne muscular dystrophy. Neuropathol Appl Neurobiol 37:243-256
59. Pierno S, Liantonio A, Camerino GM, De Bellis M, Cannone M, Gramegna G et al (2012) Potential benefits of taurine in the prevention of skeletal muscle impairment induced by disuse in the hindlimb-unloaded rat. Amino Acids 43:431-445
60. Dawson R Jr, Biasetti M, Messina S, Dominy J (2002) The cytoprotective role of taurine in exercise-induced muscle injury. Amino Acids 22:309-324
61. Yatabe Y, Miyakawa S, Ohmori H, Mishima H, Adachi T (2009) Effects of taurine administration on exercise. Adv Exp Med Biol 643:245-252
62. Nanobashvili J, Neumayer C, Fugl A, Punz A, Blumer R, Prager M et al (2003) Ischemia/reperfusion injury of skeletal muscle: plasma taurine as a measure of tissue damage. Surgery 133:91-100
63. Takahashi K, Ohyabu Y, Takahashi K, Solodushko V, Takatani T, Itoh T et al (2003) Taurine renders the cell resistant to ischemia-induced injury in cultured neonatal rat cardiomyocytes. J Cardiovasc Pharmacol 41:726-733
64. Tricarico D, Barbieri M, Camerino DC (2000) Taurine blocks ATP-sensitive potassium channels of rat skeletal muscle fibres interfering with the sulphonylurea receptor. Br J Pharmacol 130:827-834
65. Tricarico D, Barbieri M, Conte Camerino D (2001) Voltage-dependent antagonist/agonist actions of taurine on Ca(2+)-activated potassium channels of rat skeletal muscle fibers. J Pharmacol Exp Ther 298:1167-1171
66. Suzuki T, Nagao A, Suzuki T (2011) Human mitochondrial diseases caused by lack of taurine modification in mitochondrial tRNAs. Wiley Interdiscip Rev RNA 2:376-386
67. Heird WC (2004) Taurine in neonatal nutrition-revisited. Arch Dis Child Fetal Neonatal Ed 89:F473-F474
68. Wharton BA, Morley R, Isaacs EB, Cole TJ, Lucas A (2004) Low plasma taurine and later neurodevelopment. Arch Dis Child Fetal Neonatal Ed 89:F497-F498
69. Martin-Gronert MS, Ozanne SE (2007) Experimental IUGR and later diabetes. J Intern Med 261:437-452
70. Merezak S, Reusens B, Renard A, Goosse K, Kalbe L, Ahn MT et al (2004) Effect of maternal low-protein diet and taurine on the vulnerability of adult Wistar rat islets to cytokines. Diabetologia 47:669-675
71. Mortensen OH, Olsen HL, Frandsen L, Nielsen PE, Nielsen FC, Grunnet N et al (2010) Gestational protein restriction in mice has pronounced effects on gene expression in newborn offspring's liver and skeletal muscle; protective effect of taurine. Pediatr Res 67:47-53
72. Reusens B, Sparre T, Kalbe L, Bouckenooghe T, Theys N, Kruhøffer M et al (2008) The intrauterine metabolic environment modulates the gene expression pattern in fetal rat islets: prevention by maternal taurine supplementation. Diabetologia 51:836-845
73. De Luca A, Conte Camerino D, Failli P, Franconi F, Giotti A (1990) Effects of taurine on mammalian skeletal muscle fiber during development. Prog Clin Biol Res 351:163-173
74. Conte Camerino D, De Luca A, Mambrini M, Vrbova G (1989) Membrane ionic conductances in normal and denervated skeletal muscle of the rat during development. Pflugers Archiv. 413:568-570
75. Steinmeyer K, Ortland C, Jentsch TJ (1991) Primary structure and functional expression of a developmentally regulated skeletal muscle chloride channel. Nature 354:301-304
76. Yoshioka Y, Masuda T, Nakano H, Miura H, Nakaya S, Itazawa S (2002) In vitro 1H-NMR spectroscopic analysis of metabolites in fast- and slow-twitch muscles of young rats. Magn Reson Med Sci 1:7-13
77. Hammarqvist F, Angsten G, Meurling S, Andersson K, Wernerman J (2010) Age-related changes of muscle and plasma amino acids in healthy children. Amino Acids 39:359-366
78. de Boo HA, Harding JE (2007) Taurine as a marker for foetal wellbeing? Neonatology 91:145-154
79. Uozumi Y, Ito T, Hoshino Y, Mohri T, Maeda M, Takahashi K et al (2006) Myogenic differentiation induces taurine transporter in association with taurine mediated cytoprotection in skeletal muscles. Biochem J 394:699-706
80. Miyazaki T, Honda A, Ikegami T, Matsuzaki Y (2013) The role of taurine on skeletal muscle cell differentiation. Adv Exp Med Biol 776:321-328
81. Stuerenburg HJ, Stangneth B, Schoser BG (2006) Age related profiles of free amino acids in human skeletal muscle. Neuro Endocrinol Lett 27:133-136
82. De Luca A, Conte Camerino D (1992) Effects of aging on the mechanical threshold of rat skeletal muscle fibers. Pflugers Arch 420:407-409
83. De Luca A, Tricarico D, Pierno S, Conte Camerino D (1994) Aging and chloride channel regulation in rat fast-twitch muscle fibres. Pflugers Arch 427:80-85
84. Pierno S, De Luca A, Camerino C, Huxtable RJ, Conte Camerino D (1998) Chronic administration of taurine to aged rats improves the electrical and contractile properties of skeletal muscle fibers. J Pharmacol Exp Ther 286:1183-1190
85. Ito T, Yoshikawa N, Inui T, Miyazaki N, Schaffer SW, Azuma J (2014) Tissue depletion of taurine accelerates skeletal muscle senescence and leads to early death in mice. PLoS One 9:e107409
86. Rolland JF, De Luca A, Burdi R, Andreetta F, Confalonieri P, Conte Camerino D (2006) Overactivity of exercise-sensitive cation channels and their impaired modulation by IGF-1 in mdx native muscle fibers: beneficial effect of pentoxifylline. Neurobiol Dis 24:466-474
87. Grounds MD, Radley HG, Lynch GS, Nagaraju K, De Luca A (2008) Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy. Neurobiol Dis 31:1-19
88. Allen DG, Whitehead NP (2011) Duchenne muscular dystrophy-what causes the increased membrane permeability in skeletal muscle? Int J Biochem Cell Biol 43:290-294
89. De Luca A, Pierno S, Liantonio A, Cetrone M, Camerino C, Simonetti S et al (2001) Alteration of excitation-contraction coupling mechanism in extensor digitorum longus muscle fibres of dystrophic mdx mouse and potential efficacy of taurine. Br J Pharmacol 132:1047-1054
90. De Luca A, Pierno S, Liantonio A, Cetrone M, Camerino C, Fraysse B et al (2003) Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1. J Pharmacol Exp Ther 304:453-463
91. McIntosh L, Granberg KE, Brière KM, Anderson JE (1998) Nuclear magnetic resonance spectroscopy study of muscle growth, mdx dystrophy and glucocorticoid treatments: correlation with repair. NMR Biomed 11:1-10
92. McIntosh LM, Baker RE, Anderson JE (1998) Magnetic resonance imaging of regenerating and dystrophic mouse muscle. Biochem Cell Biol 76:532-541
93. Griffin JL, Des Rosiers C (2009) Applications of metabolomics and proteomics to the mdxmouse model of Duchenne muscular dystrophy: lessons from downstream of the transcriptome. Genome Med 1:32
94. Martins-Bach AB, Bloise AC, Vainzof M, Rahnamaye Rabbani S (2012) Metabolic profile of dystrophic mdx mouse muscles analyzed with in vitro magnetic resonance spectroscopy (MRS). Magn Reson Imaging 30:1167-1176
95. Xu S, Pratt SJ, Spangenburg EE, Lovering RM (2012) Early metabolic changes measured by 1H MRS in healthy and dystrophic muscle after injury. J Appl Physiol 113:808-816
96. Burdi R, Rolland JF, Fraysse B, Litvinova K, Cozzoli A, Giannuzzi V et al (2009) Multiple pathological events in exercised dystrophic mdx mice are targeted by pentoxifylline: outcome of a large array of in vivo and ex vivo tests. J Appl Physiol 106:1311-1324
97. Horvath DM (2011) The effect of taurine on dystrophic muscle tissue function. PhD thesis. Victoria University
98. Fraysse B, Liantonio A, Cetrone M, Burdi R, Pierno S, Frigeri A et al (2004) The alteration of calcium homeostasis in adult dystrophic mdx muscle fibers is worsened by a chronic exercise in vivo. Neurobiol Dis 17:144-154
99. Shkryl VM, Martins AS, Ullrich ND, Nowycky MC, Niggli E, Shirokova N (2009) Reciprocal amplification of ROS and Ca(2+) signals in stressed mdx dystrophic skeletal muscle fibers. Pflugers Arch 458:915-928
100. Whitehead NP, Yeung EW, Froehner SC, Allen DG (2010) Skeletal muscle NADPH oxidase is increased and triggers stretch-induced damage in the mdx mouse. PLoS One 5:e15354
101. Khairallah RJ, Shi G, Sbrana F, Prosser BL, Borroto C, Mazaitis MJ et al (2012) Microtubules underlie dysfunction in duchenne muscular dystrophy. Sci Signal 5:ra56
102. Marcinkiewicz J, Kontny E (2014) Taurine and inflammatory diseases. Amino Acids 46:7-20
103. Song MK, Salam NK, Roufogalis BD, Huang TH (2011) Lycium barbarum (Goji Berry) extracts and its taurine component inhibit PPAR-γ-dependent gene transcription in human retinal pigment epithelial cells: possible implications for diabetic retinopathy treatment. Biochem Pharmacol 82:1209-1218
104. Pierno S, Nico B, Burdi R, Liantonio A, Didonna MP, Cippone V et al (2007) Role of tumour necrosis factor alpha, but not of cyclo-oxygenase-2-derived eicosanoids, on functional and morphological indices of dystrophic progression in mdx mice: a pharmacological approach. Neuropathol Appl Neurobiol 33:344-359
105. De Luca A, Nico B, Rolland JF, Cozzoli A, Burdi R, Mangieri D et al (2008) Gentamicin treatment in exercised mdx mice: identification of dystrophin-sensitive pathways and evaluation of efficacy in work-loaded dystrophic muscle. Neurobiol Dis 32:243-253
106. Gehrig SM, van der Poel C, Sayer TA, Schertzer JD, Henstridge DC, Church JE et al (2012) Hsp72 preserves muscle function and slows progression of severe muscular dystrophy. Nature 4(484):394-398
107. Terrill JR, Boyatzis A, Grounds MD, Arthur PG (2013) Treatment with the cysteine precursor l-2-oxothiazolidine-4-carboxylate (OTC) implicates taurine deficiency in severity of dystropathology in mdx mice. Int J Biochem Cell Biol 45:2097-2108
108. Pan C, Giraldo GS, Prentice H, Wu JY (2010) Taurine protection of PC12 cells against endoplasmic reticulum stress induced by oxidative stress. J Biomed Sci 17:S17
109. Batista TM, da Silva PM, Amaral AG, Ribeiro RA, Boschero AC, Carneiro EM (2013) Taurine supplementation restores insulin secretion and reduces ER stress markers in protein-malnourished mice. Adv Exp Med Biol 776:129-139
110. Abebe W, Mozaffari MS (2011) Role of taurine in the vasculature: an overview of experimental and human studies. Am J Cardiovasc Dis 1:293-311
111. Pierno S, Desaphy JF, Liantonio A, De Bellis M, Bianco G, De Luca A et al (2002) Change of chloride ion channel conductance is an early event of slow-to-fast fibre type transition during unloading-induced muscle disuse. Brain 125:1510-1521
112. Desaphy JF, Pierno S, Liantonio A, Giannuzzi V, Digennaro C, Dinardo MM et al (2010) Antioxidant treatment of hindlimb-unloaded mouse counteracts fiber type transition but not atrophy of disused muscles. Pharmacol Res 61:553-563
113. Desaphy JF, Pierno S, Léoty C, George AL Jr, De Luca A, Camerino DC (2001) Skeletal muscle disuse induces fibre type-dependent enhancement of Na(+) channel expression. Brain. 124:1100-1113
114. Bastide B, Kischel P, Puterflam J, Stevens L, Pette D, Jin JP et al (2002) Expression and functional implications of troponin T isoforms in soleus muscle fibers of rat after unloading. Pflugers Arch 444:345-352
115. Desaphy JF, Pierno S, Liantonio A, De Luca A, Didonna MP, Frigeri A et al (2005) Recovery of the soleus muscle after short- and long-term disuse induced by hindlimb unloading: effects on the electrical properties and myosin heavy chain profile. Neurobiol Dis 18:356-365
116. Fraysse B, Desaphy JF, Pierno S, De Luca A, Liantonio A, Mitolo CI et al (2003) Decrease in resting calcium and calcium entry associated with slow-to-fast transition in unloaded rat soleus muscle. FASEB J. 17:1916-1918
117. Schulte LM, Navarro J, Kandarian SC (1993) Regulation of sarcoplasmic reticulum calcium pump gene expression by hindlimb unweighting. Am J Physiol 264:C1308-C1315
118. Fitts RH, Riley DR, Widrick JJ (2001) Functional and structural adaptations of skeletal muscle to microgravity. J Exp Biol Sep 204:3201-3208
119. Adams GR, Caiozzo VJ, Baldwin KM (2003) Skeletal muscle unweighting: spaceflight and ground-based models. J Appl Physiol 95:2185-2201
120. Paddon-Jones D, Sheffield-Moore M, Urban RJ, Sanford AP, Aarsland A, Wolfe RR et al (2004) Essential amino acid and carbohydrate supplementation ameliorates muscle protein loss in humans during 28 days bedrest. J Clin Endocrinol Metab 89:4351-4358
121. Fitts RH, Romatowski JG, Peters JR, Paddon-Jones D, Wolfe RR, Ferrando AA (2007) The deleterious effects of bed rest on human skeletal muscle fibers are exacerbated by hypercortisolemia and ameliorated by dietary supplementation. Am J Physiol Cell Physiol 293:C313-C320
122. Leach CS, Rambaut PC, Fischer CL (1975) A comparative study of two methods of urine preservation. Clin Biochem 8:108-117
123. Grichko VP, Heywood-Cooksey A, Kidd KR, Fitts RH (2000) Substrate profile in rat soleus muscle fibers after hindlimb unloading and fatigue. J Appl Physiol 88:473-478
124. Ojala BE, Page LA, Moore MA, Thompson LV (2001) Effects of inactivity on glycolytic capacity of single skeletal muscle fibers in adult and aged rats. Biol Res Nurs 3:88-95
125. Stein TP, Wade CE (2005) Metabolic consequences of muscle disuse atrophy. J Nutr 135:1824S-1828S
126. Murton AJ, Constantin D, Greenhaff PL (2008) The involvement of the ubiquitin proteasome system in human skeletal muscle remodelling and atrophy. Biochim Biophys Acta 1782:730-743
127. Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R et al (2001) Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 3:1014-1019
128. Yamamoto D, Ikeshita N, Matsubara T, Tasaki H, Herningtyas EH, Toda K et al (2008) GHRP-2, a GHS-R agonist, directly acts on myocytes to attenuate the dexamethasone-induced expressions of muscle-specific ubiquitin ligases, Atrogin-1 and MuRF1. Life Sci 82:460-466
129. Ito T, Schaffer SW, Azuma J (2012) The potential usefulness of taurine on diabetes mellitus and its complications. Amino Acids 42:1529-1539
130. Franconi F, Bennardini F, Mattana A, Miceli M, Ciuti M, Mian M et al (1995) Plasma and platelet taurine are reduced in subjects with insulin-dependent diabetes mellitus: effects of taurine supplementation. Am J Clin Nutr 61:1115-1119
131. Elizarova EP, Nedosugova LV (1996) First experiments in taurine administration for diabetes mellitus. The effect on erythrocyte membranes. Adv Exp Med Biol 403:583-588
132. Nakamura T, Ushiyama C, Suzuki S, Shimada N, Ohmuro H, Ebihara I et al (1999) Effects of taurine and vitamin E on microalbuminuria, plasma metalloproteinase-9, and serum type IV collagen concentrations in patients with diabetic nephropathy. Nephron. 83:361-362
133. Chauncey KB, Tenner TE Jr, Lombardini JB, Jones BG, Brooks ML, Warner RD et al (2003) The effect of taurine supplementation on patients with type 2 diabetes mellitus. Adv Exp Med Biol 526:91-96
134. Brøns C, Spohr C, Storgaard H, Dyerberg J, Vaag A (2004) Effect of taurine treatment on insulin secretion and action, and on serum lipid levels in overweight men with a genetic predisposition for type II diabetes mellitus. Eur J Clin Nutr 58:1239-1247
135. Moloney MA, Casey RG, O'Donnell DH, Fitzgerald P, Thompson C, Bouchier-Hayes DJ (2010) Two weeks taurine supplementation reverses endothelial dysfunction in young male type 1 diabetics. Diab Vasc Dis Res 7:300-310
136. Xiao C, Giacca A, Lewis GF (2008) Oral taurine but not N-acetylcysteine ameliorates NEFA-induced impairment in insulin sensitivity and beta cell function in obese and overweight, non-diabetic men. Diabetologia 51:139-146
137. Bergamini L, Mutani R, Delsedime M, Durelli L (1974) First clinical experience on the antiepileptic action of taurine. Eur Neurol 11:261-269
138. Azuma J, Sawamura A, Awata N, Ohta H, Hamaguchi T, Harada H et al (1985) Therapeutic effect of taurine in congestive heart failure: a double-blind crossover trial. Clin Cardiol 8:276-282
139. Fujita T, Ando K, Noda H, Ito Y, Sato Y (1987) Effects of increased adrenomedullary activity and taurine in young patients with borderline hypertension. Circulation 75:525-532
140. Dunn-Lewis C, Kraemer WJ, Kupchak BR, Kelly NA, Creighton BA, Luk HY et al (2011) A multi-nutrient supplement reduced markers of inflammation and improved physical performance in active individuals of middle to older age: a randomized, double-blind, placebo-controlled study. Nutr J 10:90
141. Pearl PL, Schreiber J, Theodore WH, McCarter R, Barrios ES, Yu J et al (2014) Taurine trial in succinic semialdehyde dehydrogenase deficiency and elevated CNS GABA. Neurology 18(82):940-944
142. González-Contreras J, Villalobos Gámez JL, Gómez-Sánchez AI, García-Almeida JM, Enguix Armanda A, Rius Díaz F et al (2012) Cholestasis induced by total parenteral nutrition: effects of the addition of Taurine (Tauramin®) on hepatic function parameters; possible synergistic action of structured lipids (SMOFlipid®). Nutr Hosp 27:1900-1907
143. Rosa FT, Freitas EC, Deminice R, Jordão AA, Marchini JS (2014) Oxidative stress and inflammation in obesity after taurine supplementation: a double-blind, placebo-controlled study. Eur J Nutr 53:823-830
144. Galloway SD, Talanian JL, Shoveller AK, Heigenhauser GJ, Spriet LL (2008) Seven days of oral taurine supplementation does not increase muscle taurine content or alter substrate metabolism during prolonged exercise in humans. J Appl Physiol 105:643-651
145. Spriet LL, Whitfield J (2015) Taurine and skeletal muscle function. Curr Opin Clin Nutr Metab Care. 18:96-101
146. Tappaz ML (2004) Taurine biosynthetic enzymes and taurine transporter: molecular identification and regulations. Neurochem Res 29:83-96
147. Ghandforoush-Sattari M, Mashayekhi S, Krishna CV, Thompson JP, Routledge PA (2010) Pharmacokinetics of oral taurine in healthy volunteers. J Amino Acids 346237
148. Balshaw TG, Bampouras TM, Barry TJ, Sparks SA (2013) The effect of acute taurine ingestion on 3-km running performance in trained middle-distance runners. Amino Acids 44:555-561
149. Ra SG, Miyazaki T, Ishikura K, Nagayama H, Suzuki T, Maeda S et al (2013) Additional effects of taurine on the benefits of BCAA intake for the delayed-onset muscle soreness and muscle damage induced by high-intensity eccentric exercise. Adv Exp Med Biol 776:179-187
150. da Silva LA, Tromm CB, Bom KF, Mariano I, Pozzi B, da Rosa GL et al (2014) Effects of taurine supplementation following eccentric exercise in young adults. Appl Physiol Nutr Metab 39:101-104
151. Pechlivanis A, Kostidis S, Saraslanidis P, Petridou A, Tsalis G, Veselkov K et al (2013) 1H NMR study on the short- and long-term impact of two training programs of sprint running on the metabolic fingerprint of human serum. J Proteome Res 4(12):470-480
152. Gregor P, Hoff M, Holik J, Hadley D, Fang N, Coon H et al (1994) Dinucleotide repeat polymorphism in the human taurine transporter gene (TAUT). Hum Mol Genet 3:2263
153. Han X, Patters AB, Jones DP, Zelikovic I, Chesney RW (2006) The taurine transporter: mechanisms of regulation. Acta Physiol (Oxf) 187:61-73
154. Finlay EK, Berry DP, Wickham B, Gormley EP, Bradley DG (2012) A genome wide association scan of bovine tuberculosis susceptibility in Holstein-Friesian dairy cattle. PLoS One 7:e30545